Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.

NCT01446445 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Infection in Solid Organ Transplant Recipients

Interventions

DRUG: Ganciclovir/ Valganciclovir according to SPC
DRUG: Ganciclovir/ Valganciclovir according to PK model

Sponsor

Nuria Lloberas

Collaborators

[object Object]